Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 20;19(1):19.
doi: 10.1186/s12957-021-02123-7.

Atypical parathyroid adenoma: clinical and anatomical pathologic features

Affiliations

Atypical parathyroid adenoma: clinical and anatomical pathologic features

Alessandro Galani et al. World J Surg Oncol. .

Abstract

Background: Primary hyperparathyroidism is an endocrine pathology that affects calcium metabolism. Patients with primary hyperparathyroidism have high concentrations of serum calcium or high concentrations of parathyroid hormone, or incorrect parathyroid hormone levels for serum calcium values. Primary hyperparathyroidism is due to the presence of an adenoma/single-gland disease in 80-85%. Multiple gland disease or hyperplasia accounts for 10-15% of cases of primary hyperparathyroidism. Atypical parathyroid adenoma and parathyroid carcinoma are both responsible for about 1.2-1.3% and 1% or less of primary hyperparathyroidism, respectively.

Methods: We performed a retrospective cohort study and enrolled 117 patients with primary hyperparathyroidism undergoing minimally invasive parathyroidectomy. Histological and immunohistochemical examination showed that 107 patients (91.5%) were diagnosed with typical adenoma (group A), while 10 patients (8.5%) were diagnosed with atypical parathyroid adenoma (group B). None of the patients were affected by parathyroid carcinoma.

Results: Significant statistical differences were found in histological and immunohistochemical parameters as pseudocapsular invasion (p < 0.001), bands of fibrosis (p < 0.001), pronounced trabecular growth (p < 0.001), mitotic rates of > 1/10 high-power fields (HPFs) (p < 0.001), nuclear pleomorphism (p = 0.036), thick capsule (p < 0.001), Ki-67+ > 4% (p < 0.001), galectin-3 + (p = 0.002), and protein gene product (PGP) 9.5 + (p = 0.038).

Conclusions: Atypical parathyroid adenoma is a tumor that has characteristics both of typical adenoma and parathyroid carcinoma. The diagnosis is reached by excluding with strict methods the presence of malignancy criteria. Atypical parathyroid adenoma compared to typical adenoma showed significant clinical, hematochemical, histological, and immunohistochemical differences. We did not find any disease relapse in the 10 patients with atypical parathyroid adenoma during 60 months of follow-up time.

Keywords: Atypical parathyroid adenoma; Minimally invasive parathyroidectomy; Parathyroid carcinoma; Primary hyperparathyroidism; Typical adenoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
a Pseudocapsular invasion: cell proliferation is closer with capsular and vascular structures in the atypical parathyroid adenoma but there is no sure invasion (hematoxylin and eosin (H&E) staining, × 40 original magnification). b Pseudocapsular invasion: immunohistochemical staining for CD31/CD34 underlining the vascular plot allows to verify if there is an invasion of tumor cells and therefore improve diagnostic quality (× 40 original magnification)
Fig. 2
Fig. 2
Nuclear pleomorphism: characteristic dosimetry and hyperchromasia of tumor cells nuclei in high-power view section of atypical parathyroid adenoma (H&E staining, × 100 original magnification)
Fig. 3
Fig. 3
Thick capsule: a characteristic of the atypical parathyroid adenoma is also present in parathyroid carcinoma; therefore, it requires a strict differential diagnosis (H&E, × 40 original magnification)
Fig. 4
Fig. 4
a Ki-67+ > 4%: immunohistochemical staining for Ki-67 underlines the high mitotic rates of APA (MIB/Ki-67, × 40 original magnification). b Ki-67+ < 4%: immunohistochemical staining for Ki-67 underlines the low mitotic rates of TA (MIB/Ki-67, × 40 original magnification)
Fig. 5
Fig. 5
a Galectin-3+: immunohistochemistry for Galectin-3 shows widespread and marked cytoplasmic and nuclear staining of APA (× 400 original magnification). b Galectin-3 +: immunohistochemistry for galectin-3 shows weakly cytoplasmic and nuclear staining of TA (× 400 original magnification)

References

    1. Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018;391(10116):168–178. doi: 10.1016/S0140-6736(17)31430-7. - DOI - PubMed
    1. Vaira V, Verdelli C, Forno I, Corbetta S. MicroRNAs in parathyroid physiopathology. Mol Cell Endocrinol. 2017;456:9–15. doi: 10.1016/j.mce.2016.10.035. - DOI - PubMed
    1. Gasser RW. Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy. Wien Med Wochenschr. 2013;163(17–18):397–402. doi: 10.1007/s10354-013-0235-z. - DOI - PubMed
    1. Saponaro F, Cetani F, Repaci A, et al. Clinical presentation and management of patients with primary hyperparathyroidism in Italy. J Endocrinol Investig. 2018;41(11):1339–1348. doi: 10.1007/s40618-018-0879-z. - DOI - PubMed
    1. Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145–158. doi: 10.1016/S0140-6736(09)60507-9. - DOI - PubMed

Substances

LinkOut - more resources